• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人脑质子-有机阳离子转运体的底物及其与有机阳离子转运体 1 活性的比较。

Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.

机构信息

Institute of Clinical Pharmacology, University Medical Center, Georg-August University, Robert-Koch-Str. 40, 37075 Göttingen, Germany.

出版信息

Int J Mol Sci. 2022 Jul 29;23(15):8430. doi: 10.3390/ijms23158430.

DOI:10.3390/ijms23158430
PMID:35955563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9369162/
Abstract

Many organic cations (OCs) may be transported through membranes by a genetically still uncharacterized proton-organic cation (H + OC) antiporter. Here, we characterized an extended substrate spectrum of this antiporter. We studied the uptake of 72 drugs in hCMEC/D3 cells as a model of the human blood-brain barrier. All 72 drugs were tested with exchange transport assays and the transport of 26 of the drugs was studied in more detail concerning concentration-dependent uptake and susceptibility to specific inhibitors. According to exchange transport assays, 37 (51%) drugs were good substrates of the H + OC antiporter. From 26 drugs characterized in more detail, 23 were consistently identified as substrates of the H + OC antiporter in six different assays and transport kinetic constants could be identified with intrinsic clearances between 0.2 (ephedrine) and 201 (imipramine) mL × minute × g protein. Excellent substrates of the H + OC antiporter were no substrates of organic cation transporter OCT1 and vice versa. Good substrates of the H + OC antiporter were more hydrophobic and had a lower topological polar surface area than non-substrates or OCT1 substrates. These data and further research on the H + OC antiporter may result in a better understanding of pharmacokinetics, drug-drug interactions and variations in pharmacokinetics.

摘要

许多有机阳离子(OCs)可能通过一种尚未被基因鉴定的质子-有机阳离子(H + OC)反向转运体通过膜转运。在这里,我们描述了该反向转运体的扩展底物谱。我们研究了 72 种药物在 hCMEC/D3 细胞中的摄取,作为人血脑屏障的模型。所有 72 种药物均通过交换转运测定进行了测试,其中 26 种药物的摄取进行了更详细的研究,包括浓度依赖性摄取和对特定抑制剂的敏感性。根据交换转运测定,37 种(51%)药物是 H + OC 反向转运体的良好底物。在更详细地描述的 26 种药物中,有 23 种在六种不同的测定中被一致鉴定为 H + OC 反向转运体的底物,并且可以确定转运动力学常数,内在清除率在 0.2(麻黄碱)和 201(丙咪嗪)mL×分钟×g 蛋白之间。H + OC 反向转运体的良好底物不是有机阳离子转运蛋白 OCT1 的底物,反之亦然。H + OC 反向转运体的良好底物比非底物或 OCT1 底物具有更高的疏水性和更低的拓扑极性表面积。这些数据以及对 H + OC 反向转运体的进一步研究可能会更好地理解药代动力学,药物相互作用和药代动力学的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/3407f013683a/ijms-23-08430-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/fcbe68e55549/ijms-23-08430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/a9d233b6aa9e/ijms-23-08430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/c72f234f5983/ijms-23-08430-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/e97ec22ef1a1/ijms-23-08430-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/044a8eccf750/ijms-23-08430-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/3407f013683a/ijms-23-08430-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/fcbe68e55549/ijms-23-08430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/a9d233b6aa9e/ijms-23-08430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/c72f234f5983/ijms-23-08430-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/e97ec22ef1a1/ijms-23-08430-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/044a8eccf750/ijms-23-08430-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/555c/9369162/3407f013683a/ijms-23-08430-g006.jpg

相似文献

1
Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.人脑质子-有机阳离子转运体的底物及其与有机阳离子转运体 1 活性的比较。
Int J Mol Sci. 2022 Jul 29;23(15):8430. doi: 10.3390/ijms23158430.
2
The mystery of the human proton-organic cation antiporter: One transport protein or many?人类质子-有机阳离子反向转运蛋白的奥秘:一种转运蛋白还是多种?
Pharmacol Ther. 2022 Nov;239:108283. doi: 10.1016/j.pharmthera.2022.108283. Epub 2022 Sep 24.
3
Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.通过质子偶联有机阳离子转运体摄取苯海拉明类似物进入 hCMEC/D3 细胞的结构要求。
J Pharm Sci. 2021 Jan;110(1):397-403. doi: 10.1016/j.xphs.2020.09.001. Epub 2020 Sep 6.
4
A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.质子偶联有机阳离子转运体参与乌头生物碱的血脑屏障转运。
J Ethnopharmacol. 2020 Apr 24;252:112581. doi: 10.1016/j.jep.2020.112581. Epub 2020 Jan 20.
5
An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters.质子有机阳离子反向转运体的扩展底物谱及其与其他阳离子转运体的关系。
Basic Clin Pharmacol Toxicol. 2024 Dec;135(6):720-742. doi: 10.1111/bcpt.14090. Epub 2024 Oct 21.
6
Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.质子偶联有机阳离子反向转运体介导阿扑吗啡对映体在人脑微血管内皮细胞系hCMEC/D3中的摄取。
Biol Pharm Bull. 2014;37(2):286-91. doi: 10.1248/bpb.b13-00773. Epub 2013 Nov 20.
7
The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.假定的质子偶联有机阳离子转运体参与了曲坦类药物进入人脑毛细血管内皮细胞的摄取。
Fluids Barriers CNS. 2024 May 6;21(1):39. doi: 10.1186/s12987-024-00544-6.
8
How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.精神兴奋剂如何进入人脑?质子-有机阳离子转运体的作用分析。
Biochem Pharmacol. 2021 Oct;192:114751. doi: 10.1016/j.bcp.2021.114751. Epub 2021 Aug 28.
9
Involvement of Proton-Coupled Organic Cation Antiporter in Human Blood-Brain Barrier Transport of Mesoridazine and Metoclopramide.质子偶联有机阳离子转运体在人血脑屏障中麦罗昔康和甲氧氯普胺转运中的作用。
Biol Pharm Bull. 2024;47(10):1662-1667. doi: 10.1248/bpb.b24-00329.
10
Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.质子偶联有机阳离子转运体在缬尼卡林通过血脑屏障的转运及在人脑血管内皮细胞中的作用。
J Pharm Sci. 2017 Sep;106(9):2576-2582. doi: 10.1016/j.xphs.2017.04.032. Epub 2017 Apr 26.

引用本文的文献

1
Acute hypobaric hypoxia attenuates the anti-fatigue effects of pitolisant by downregulating the expression of organic cation transporter 1 and P-glycoprotein.急性低压缺氧通过下调有机阳离子转运体1和P-糖蛋白的表达减弱匹莫林的抗疲劳作用。
Front Pharmacol. 2025 Apr 16;16:1564174. doi: 10.3389/fphar.2025.1564174. eCollection 2025.
2
Region-independent active CNS net uptake of marketed H/OC antiporter system substrates.市售H/OC转运体系统底物在中枢神经系统中存在不依赖区域的活性净摄取。
Front Cell Neurosci. 2024 Oct 29;18:1493644. doi: 10.3389/fncel.2024.1493644. eCollection 2024.
3
Sex-Dependent Effects of CYP2D6 on the Pharmacokinetics of Berberine in Humans.

本文引用的文献

1
Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1.有机阳离子转运体 1 的抑制、转运和增强转运之间的关系。
Int J Mol Sci. 2022 Feb 11;23(4):2007. doi: 10.3390/ijms23042007.
2
Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line.基于药效团的人脑微血管内皮hCMEC/D3细胞系中新型药物/质子反向转运体底物的发现
Pharmaceutics. 2022 Jan 21;14(2):255. doi: 10.3390/pharmaceutics14020255.
3
How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
CYP2D6对小檗碱在人体药代动力学中的性别依赖性影响。
Clin Pharmacol Ther. 2025 Jan;117(1):250-260. doi: 10.1002/cpt.3454. Epub 2024 Nov 3.
4
An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters.质子有机阳离子反向转运体的扩展底物谱及其与其他阳离子转运体的关系。
Basic Clin Pharmacol Toxicol. 2024 Dec;135(6):720-742. doi: 10.1111/bcpt.14090. Epub 2024 Oct 21.
5
The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.假定的质子偶联有机阳离子转运体参与了曲坦类药物进入人脑毛细血管内皮细胞的摄取。
Fluids Barriers CNS. 2024 May 6;21(1):39. doi: 10.1186/s12987-024-00544-6.
6
Atypical Substrates of the Organic Cation Transporter 1.有机阳离子转运蛋白 1 的非典型底物。
Biomolecules. 2022 Nov 9;12(11):1664. doi: 10.3390/biom12111664.
精神兴奋剂如何进入人脑?质子-有机阳离子转运体的作用分析。
Biochem Pharmacol. 2021 Oct;192:114751. doi: 10.1016/j.bcp.2021.114751. Epub 2021 Aug 28.
4
Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related Pain.癌痛患者中羟考酮及其代谢产物的群体药代动力学
Cancers (Basel). 2021 Jun 2;13(11):2768. doi: 10.3390/cancers13112768.
5
Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients.CYP2D6、CYP2C19基因多态性及有机阳离子转运体OCT1对健康志愿者和抑郁症患者阿米替林药代动力学的影响。
Front Pharmacol. 2021 May 21;12:688950. doi: 10.3389/fphar.2021.688950. eCollection 2021.
6
Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation.利用机器学习引导的虚拟筛选和实验验证鉴定新型OCT1高亲和力底物
J Med Chem. 2021 Mar 11;64(5):2762-2776. doi: 10.1021/acs.jmedchem.0c02047. Epub 2021 Feb 19.
7
PubChem in 2021: new data content and improved web interfaces.PubChem 在 2021 年:新增数据内容和改进的网络界面。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1388-D1395. doi: 10.1093/nar/gkaa971.
8
Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.通过质子偶联有机阳离子转运体摄取苯海拉明类似物进入 hCMEC/D3 细胞的结构要求。
J Pharm Sci. 2021 Jan;110(1):397-403. doi: 10.1016/j.xphs.2020.09.001. Epub 2020 Sep 6.
9
A guide to plasma membrane solute carrier proteins.质膜溶质载体蛋白指南。
FEBS J. 2021 May;288(9):2784-2835. doi: 10.1111/febs.15531. Epub 2020 Sep 18.
10
A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.质子偶联有机阳离子转运体参与乌头生物碱的血脑屏障转运。
J Ethnopharmacol. 2020 Apr 24;252:112581. doi: 10.1016/j.jep.2020.112581. Epub 2020 Jan 20.